TAFINLAR is indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test. TAFINLAR is indicated, in combination with trametinib, for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test.

Where can I buy Tafinlar?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Tafinlar (dabrafenib) on prescription and Import License in Patient's Name only.

For Tafinlar or dabrafenib price in India.
Please contact +91 9811747774 or neeraj@indianpharmanetwork.co.in
Tafinlar (dabrafenib)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals Tafinlar (dabrafenib) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

Capsules: 50 mg, 75 mg.

ReadMore

FDA News Release

FDA grants priority review to Tafinlar plus Mekinist for adjuvant treatment of BRAF-positive melanoma.
Dated: December 22, 2017

ReadMore